Morning Movers
Watch us on YouTube Live at 8:30AM EST

NFLX.NQ -0.95%
Netflix Inc – Forecast third-quarter paid subscriber additions below Wall Street estimates as the streaming giant faces intense competition. Apart from production delays, newer entrants in the streaming space such as Disney+, HBO Max and Apple TV+ are touting rich content libraries and competitive pricing. Netflix said it expects to add 3.50 million paid subscribers in the third quarter, compared with analysts’ estimates of 5.51 million, according to IBES data from Refinitiv. The company said it added 1.54 million paid subscribers during the second quarter ending June 30, beating analysts’ estimates of 1.04 million. Reported revenue of $7.48B vs. $7.48B consensus, EPS of $2.55 vs. $2.17 consensus.

UAL.NQ 1.04%
United Airlines – Reduced its quarterly loss to $434 million and posted surprisingly strong revenue as U.S. vacation travel picked up. United said it can become profitable this year without more government money. Wall Street expects losses in both the third and fourth quarters. The company said it’s second-quarter loss would have been far worse — $1.3 billion — without more than $1 billion in federal pandemic aid. Still, the loss was much smaller than the $1.63 billion United lost a year earlier and the $1.36 billion loss it suffered in the first quarter of this year.

XPEV.NY 1.72%
Xpeng Inc – Shares of Chinese electric-car maker are higher premarket after filing showed e-commerce major Alibaba Group has a long position in the co, picking up 191.9 mln, or 14.97% of co’s Hong Kong shares 9868.HK. XPEV set for a fifth straight day of gains, best day in three weeks if current levels hold.

COIN.NQ 2.68%
Coinbase Global – Crypto related stocks are rallying premarket as BTC prices bounce more than 3%, Coinbase is among the most active in early trade looking to recover back above the key $220 support level.

AMC.NY -3.23%
AMC Entertainment – Along with fellow meme stock original GameStop Corp. logged their highest close since July 9th Tuesday, actively traded premarket again after rallying more than 24.5% yesterday. Possibly helping the stock was news after yesterday’s close that AMC was planning to start operating cinemas in two high-grossing locations in Los Angeles next month. Reuters reports 75.84M AMC shares were sold short as of Monday’s close, representing ~15% of its float, a decline of 4M shares over the last week, citing data from S3 Partners.

F.NY 0.93%
Ford Motor Co – Argo AI and Ford announced plans to launch self-driving vehicles on Lyft’s network by the end of 2021.

TSLA.NQ -0.42%
Tesla Inc – Shares of electric-car maker are little changed premarket after back to back solid gains, Tesla announced plans to open its network of superchargers to other electric vehicles later this year, CEO Elon Musk said on Twitter the Co’s fast charging network, with over 25,000 superchargers globally, has given it a competitive edge to this point over other carmakers like General Motors and Ford Motor.

KO.NY 1.92%
Coca-Cola Co – Raised its full-year sales and profit forecasts on Wednesday, as demand rebounds for its beverages from the re-opening of theaters, restaurants and stadiums. Annual adjusted earnings per share are expected to rise 13% to 15%, compared with a prior forecast of a high single digits to low double digits increase. Net revenue rose 42% to $10.1 billion in the second quarter ended July 2. The company had reported a 28% slump in total net revenues in the year-ago quarter due to the lockdowns.

NURO.NQ 22.01%
NeuroMetrix Inc – Shares skyrocketed 241% yesterday hitting a two-year high on record volume, after the micro-cap Massachusetts-based medical device company said its Quell transcutaneous electric nerve stimulator received “Breakthrough Designation” from the Food and Drug Administration to treat fibromyalgia symptoms in adults.

CEMI.NQ 102.40%
Chembio Diagnostics Inc – Announced it has received a $28.3 million purchase order from Bio-Manguinhos for Dpp Sars-Cov-2 Antigen Tests in Brazil.

LEXX.NQ 42.64%
Lexaria Bioscience Corp – Announced positive tolerability and pharmacokinetic study results for its VIRAL-A20-3. DehydraTECHTM enabled colchicine, is the latest of several drugs Lexaria has successfully tested with known SARS-CoV-2 antiviral properties.

Leave a Reply

Your email address will not be published.